Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Algeciras-Schimnich

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 5, 1999
Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosisA Algeciras-Schimnich, T S Griffith, D H Lynch, et al.
The Journal of Biological Chemistry|August 7, 1999
Protein kinase C and calcineurin synergize to activate IkappaB kinase and NF-kappaB in T lymphocytesS A Trushin, K N Pennington, A Algeciras-Schimnich, et al.
Clinical Biochemistry|November 14, 2018
Corticotropin hormone assay interference: A case seriesD M Donegan, A Algeciras-Schimnich, O Hamidi, et al.
Clinical Pharmacology and Therapeutics|March 16, 2007
Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survivalS R Vlahakis, G D Bren, A Algeciras-Schimnich, et al.
Cell Death and Differentiation|October 23, 2004
CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8B C Barnhart, E M Pietras, A Algeciras-Schimnich, et al.
AIDS Research and Human Retroviruses|December 2, 1999
Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy numberD H Dockrell, A D Badley, A Algeciras-Schimnich, et al.
The Journal of Clinical Investigation|February 13, 2001
Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytesS R Vlahakis, A Algeciras-Schimnich, G Bou, et al.
Cytokine|January 6, 2022
Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patientsS Ashrafzadeh-Kian, M R Campbell, J C Jara Aguirre, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|May 5, 1999
Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosisA Algeciras-Schimnich, T S Griffith, D H Lynch, et al.
The Journal of Biological Chemistry|August 7, 1999
Protein kinase C and calcineurin synergize to activate IkappaB kinase and NF-kappaB in T lymphocytesS A Trushin, K N Pennington, A Algeciras-Schimnich, et al.
Clinical Biochemistry|November 14, 2018
Corticotropin hormone assay interference: A case seriesD M Donegan, A Algeciras-Schimnich, O Hamidi, et al.
Clinical Pharmacology and Therapeutics|March 16, 2007
Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survivalS R Vlahakis, G D Bren, A Algeciras-Schimnich, et al.
Cell Death and Differentiation|October 23, 2004
CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8B C Barnhart, E M Pietras, A Algeciras-Schimnich, et al.
AIDS Research and Human Retroviruses|December 2, 1999
Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy numberD H Dockrell, A D Badley, A Algeciras-Schimnich, et al.
The Journal of Clinical Investigation|February 13, 2001
Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytesS R Vlahakis, A Algeciras-Schimnich, G Bou, et al.
Cytokine|January 6, 2022
Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patientsS Ashrafzadeh-Kian, M R Campbell, J C Jara Aguirre, et al.
Pageof 1